Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Fulgent Genetics, often known simply as Fulgent, is a pioneering provider of comprehensive genomic testing and precision medicine solutions. Headquartered in the US, with significant global operational reach, the company stands at the forefront of the healthcare technology industry.
Founded in 2011, Fulgent has rapidly expanded its offerings, leveraging its proprietary next-generation sequencing (NGS) and advanced bioinformatics platforms. Their core services include an extensive menu of genetic tests for hereditary conditions, cancer diagnostics, reproductive health, and pharmacogenomics. This technology-driven approach ensures highly accurate and timely actionable insights for clinicians and patients.
Fulgent's unique blend of advanced technology and a patient-centric focus positions it as a leading force in genomic diagnostics. They empower healthcare providers and individuals with crucial genetic information to guide informed treatment and preventative care strategies.
-1 vs industry average
Fulgent Genetics’s score of 35 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Business Services is among the least carbon-intensive industries
The Business Services industry has reduced its overall emissions by 25% since 2018
Scope 3 accounts for ••• of total emissions.
Fulgent Genetics reported total Scope 1 and Scope 2 emissions of approximately 4,528,000 kg CO2e in 2023. This comprised about 576,000 kg CO2e from Scope 1 emissions and approximately 3,953,000 kg CO2e from Scope 2 emissions. This follows 2022's Scope 1 and 2 emissions of around 6,562,000 kg CO2e (2,130,000 kg CO2e Scope 1 and 4,433,000 kg CO2e Scope 2) and 2021's approximately 3,101,000 kg CO2e (1,651,000 kg CO2e Scope 1 and 1,450,000 kg CO2e Scope 2). Fulgent Genetics has not disclosed Scope 3 emissions data.
The company is committed to achieving net-zero emissions by 2050. Additionally, Fulgent Genetics aims to cut all-scopes emissions by 45% by 2030, using 2010 as a baseline.
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more